• TVTV · OTC
  • MWIP · OTCQB
  • SRBL · OTCQB
  • XCHC · OTCQB
  • GAXC · OTCQB

    • INDUSTRY NEWS

    OTC Stocks Showing Powerful Trends ACTC, ALTO, VYGO, SREH, SFMI

    Posted on December 16, 2010 by

    ACTC Leads Nightly Small-Cap Business Report

    Dec 16, 2010 Boca Raton, FL–Penny Stocks Closing on Strong Gains ACTC, ALTO, VYGO, SREH, and SFMI as a small drop in unemployment claims and a higher profit forecast by FedEx Corp. helped push stocks to two-year highs Thursday.

    Market Internals

    OTC BB Total Volume 1.4 Billion, Advancing Issues 467 Declining Issues 564

    Pick Sheets Total volume 4.5 Billion Shares, Advancing issues 1383 Declining issues 1569

    The most active bullish penny stocks at the close of trading includes: OTC ACTC, ALTO, VYGO, SREH, SFMI

    1- Advanced Cell Technology Inc. (ACTC.OB) close .1795 up 12% on 23.9 million shares traded at the close. ACTC had a healthy pullback and could be in the process of putting another leg higher.

    Advanced Cell Technology, Inc., a biotechnology company, focuses on the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine.

    2-Alto Group Holdings Inc. (ALTO.OB) close .02 up 23% on a point 7 million shares exchanging hands at the close. Traders and investors step in today as they feel there could be a potential bottom reversal in place from very oversold conditions.
    Alto Group Holdings Inc. engages in the acquisition and exploration of mineral properties in Africa and Latin America.
    3-VOYAGER PETROLEUM, I (VYGO.OB) close .0042 up a staggering 740% on massive volume of 101 million shares traded at the close.

    In a Press Release Today VYGO announced a Letter of Intent which contemplates an Exchange of capital stock of Voyager for all the outstanding capital of Scrap USA, LLC.

    Voyager Petroleum, Inc., a development stage company, manufactures and distributes petroleum-based products to the automotive and manufacturing aftermarket.

    4- Strategic Rare Earth Metals, Inc. (SREH.PK) last .0002 up 100% on enormous volume of 316.5 million shares traded.

    SREH surprised traders and investors this morning with an announcement today that it has acquired Nicaragua Gold Corp., a Canadian gold exploration and mining company with primary operations focused in Nicaragua and South America.

    Strategic Rare Earth Metals, Inc., through its subsidiary, China Laizhou Bay Mining International Corporation, engages in mining and processing granite in the People’s Republic of China.

    5-Silver Falcon Mining, Inc. (SFMI.OB) close .24 up 11% on 1.2 million shares exchanging hands at the close.

    Silver Falcon Mining, Inc., a junior resource production company, engages in the exploration and development of gold and silver mining properties in North America.

    About the Stock Wizards.net
    TSW is looking for hot penny stocks exposed such as SMCE on the move showing unusual movement that could end up being a popular top performing HOT OTC small cap penny stock picks such as ACTC. We know traders and investors are looking for exciting hot penny stock pick alerts like ACTC along with OTC volume movers to put on there speculative watch list for review.

    The TSW penny stock finder trading system locates the best small cap, micro cap penny stocks such as ACTC that have unusual movements with news, popular small cap penny stocks with big gains, and strong stock trends.

    TSW looks for exciting, explosive penny stock picks like ACTC with the right mixture of powerful volume and low market capitalization to give day-traders & investors an opportunity to build a penny stock picks trading watch list consisting of the most notable penny stocks like ACTC that have high volume with positive change that can become explosive mega volume penny stock picks at any given time.

    Get real-time penny stock pick text message alerts like ACTC sent to your cell phone.

    Disclaimer

    The assembled information distributed by TheStockWizards.net is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. TheStockWizards.net does expect that investors will buy and sell securities based on information assembled and presented herein. TheStockWizards.net will not be responsible in any way for or accept any liability for any losses arising from an investor’s reliance on or use of information obtained from our website or emails. Always do your own due diligence, and consult your financial advisor

    Penny Stock Picks ACTC

    Here Enterprises (HRTE.PK) Developing Wind Facilities to Meet Rising Demand for Green Energy

    Posted on December 20, 2010 by

    Here Enterprises, Inc. (Pink Sheets: HRTE) today announced the Company is developing its first wind farm in order to meet the growing need for clean energy. In its 2010 International Energy Outlook, the United States Department of Energy projects global energy consumption will increase 49% by 2035. Here Enterprises believes wind can play an integral role in meeting rising electricity demand while significantly reducing greenhouse gas emissions.

    Here Enterprises, Inc

    Here Enterprises, Inc

    Here Enterprises’ strategy is to co-locate wind energy facilities with commercial businesses in order to generate cashflow from the production of clean energy as well as from the businesses operating onsite. The Company recently acquired its first wind energy development project, Cycle Ranch, where it intends to develop a wind farm at Cycle Ranch Motocross Park, a popular commercial speedway with ongoing revenue near Floresville, Texas.

    According to the World Wind Energy Association, the wind market saw robust growth in the first half of 2010, with approximately 16 gigawatts of new capacity added worldwide. The total capacity of all wind turbines installed reached 175 gigawatts in mid-2010, compared with 159 gigawatts by the end of 2009. Global capacity is expected to reach nearly 200 gigawatts by year end. (World Wind Energy Association, “16 Gigawatts of Wind Power Added in First Half of 2010″, October 19, 2010)

    The United States added 395 megawatts (MW) of wind power in the third quarter of 2010, according to the American Wind Energy Association. With 1,634 MW installed through the end of September, the total installed utility-scale wind capacity through the third quarter was 36,698 MW. Over 6,300 MW is now under construction, so the U.S. is likely to end 2010 with over 5,000 MW completed. (AWEA, Third Quarter Market Report, October 2010)

    Mark Ryun, CEO of Here Enterprises, commented: “Clean, renewable wind power can dramatically reduce CO2 emissions, stabilize power prices and increase energy security, and ramp up to meet increasing requirements. At Here Enterprises we believe wind will play a critical role in solving our energy challenges and we are committed to leveraging this advantageous green energy resource.”

    About Here Enterprises, Inc. (HRTE.PK)

    Here Enterprises is a developer of wind power, our nation’s fastest growing renewable energy resource. The Company is engaged in planning, developing, acquiring and operating wind farms in the United States to generate clean, profitable wind energy. Here Enterprises is developing wind energy projects which co-locate wind farms with commercial businesses in order to maximize cashflow for each project.

    This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. HRTE has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates”, “believes”, “estimates”, “expects”, “plans”, “intends”, “potential” and similar expressions. These statements reflect HRTE’s current beliefs and are based upon information currently available to it.

    Accordingly, such forward looking statements involve known and unknown risks, uncertainties and other factors which could cause the HRTE’s actual results, performance or achievements to differ materially from those expressed in or implied by such statements. HRTE undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this press release including such forward-looking statements.

    Windhere.com

    WSHE, DGRI, UNDT, GRYO, PZG Are Moving OTC Markets at the Open

    Posted on by

    OTC Penny Stocks Best Gainers at Open WSHE, DGRI, UNDT, GRYO, PZG as markets edge up after Obama extends tax cuts.

    Dec 20, 2010 Boca Raton, FL–TheStockwizards.net analyzes the most notable explosive OTC, OTCBB, NASDAQ,  NYSE Micro Cap Penny Stocks such as  WSHE with huge volume and positive change.

    The most active bullish small cap stocks at the open of trading includes: OTC:WSHE, DGRI, UNDT, GRYO, PZG

    1-E-Debit Global Corporation (WSHE.OB) last .125 up 68% on 1 million shares traded at the open.

    WSHE

    WSHE

    E-Debit Global Corporation, through its subsidiaries, operates in the non-conventional banking industry in Canada. It sells and operates cash vending and point of sale machines.

    2-Dutch Gold Resources, Inc. (DGRI.PK) last .0291 up 16% on 7.4 million shares traded at the opening bell.

    Dutch Gold Resources, Inc. engages in the exploration, production, and development of gold reserves in North America.

    3-Universal Detection Technology (UNDT.OB) last .0007 up 133% on 141.1 million shares exchanging hands first 30 min of trading.

    UNDT announced in a press release this morning that it has entered into a distribution agreement with Brazil-based ORMAX Tecnologia em Seguranca.

    Universal Detection Technology engages in the research, development, and marketing of bioterrorism detection devices in the United States.

    4- GRYPHON RESOURCES (GRYO.PK) last price .168 up 8% on 1.6 million shares traded in the early session.

    Gryphon Resources, Inc. operates as a mineral exploration company. It focuses on mineral exploration opportunities in Turkey.

    5-Paramount Gold and Silver Corp. (PZG) last price 3.24 up 18% on 2.7 million shares exchanging hands in the early session.

    Paramount Gold and Silver Corp. engages in the acquisition, exploration, and development of gold, silver, and precious metal properties primarily in Mexico, as well as in British Columbia, Canada.

    Read the rest of this entry »

    BioCurex Inc. (BOCX.OB) RECAF(TM) Rallies 100% on News of Blood Test for Cancer Prevention

    Posted on September 11, 2011 by

    BioCurex Inc. (BOCX.OB) RECAF(TM)RICHMOND, British Columbia, Sept. 8, 2011 — BioCurex Inc. (OTCBB:BOCX.OB – News) today announced results indicating that its RECAF blood test for cancer can prevent 70% of unnecessary prostate biopsies.

    In a study to be presented at the ISOBM (International Society of Oncology and Biomarkers) annual meeting in October, BioCurex compared the performance of RECAF and free-PSA to discriminate prostate cancer from benign prostate hyperplasia (BPH), a common benign condition that requires no surgical treatment. The RECAF test outperformed the established free-PSA test by approximately 600% in its ability to prevent unnecessary prostate biopsies.

    Men over 50 years of age are screened with PSA (Prostate Specific Antigen) for prostate cancer. PSA is secreted by the prostate but it is not specific for cancer and therefore benign prostate conditions also show elevated PSA. As a result, two thirds of prostate biopsies are cancer negative and are not necessary.

    A prostate biopsy is obtained by inserting 6-12 needles into the prostate. The most common procedure is carried out from the rectum following an enema and antibiotic coverage, using ultrasound for guidance. Discomfort, bleeding and infection are the most common complications. Thus, it is important to minimize the number of unnecessary biopsies while still detecting the highest possible number of cancer cases.

    To reduce unwanted biopsies, the “free-PSA” test was developed and approved by the FDA. PSA circulates “free” as well as attached to other proteins. In the 1990′s, the percentage of free-PSA was shown to be somehow lower in cancer patients than in patients with benign conditions. Unfortunately, the number of unnecessary biopsies prevented by the free-PSA test is only 11-28% as shown in the approved FDA applications from large diagnostic companies.

    The BioCurex study was done using blinded samples from two different sources and showed that FDA approved free-PSA tests would have reduced unnecessary biopsies by 11%, whereas the RECAF test, used on the same samples, would have reduced the number of unwanted biopsies by approximately 70% while detecting a comparable percentage of cancers.

    The potential commercial impact of these results is very significant, because this is a very specific application for which there is a pressing need and which is not currently addressed in an adequate fashion.

    The standard PSA blood test costs between $20 and $60. The free-PSA blood test costs about $100. Medicare and most health insurers typically cover PSA tests for men over 50. It is estimated that in the USA alone – which represents 5% of the worldwide population – over 1.5 million men are eligible for a free-PSA test and therefore also for a RECAF test.

    Dr. Moro, BioCurex CEO stated: “We already knew that RECAF outperformed PSA to detect early stages of prostate cancer. These new results indicate that RECAF can be successfully used together with PSA to detect prostate cancer while decreasing dramatically the number of false positives when compared to FDA approved free-PSA tests. Using this combination, we can get the organ specificity of PSA (we know the lesion is in the prostate) with the high specificity of RECAF for cancer. The result can reduce unnecessary prostate biopsies by 2/3 compared to less than 30% for free-PSA FDA approved tests. We are very excited because we have received a very positive response from a number of prospect licensees and strategic alliance partners to whom we have shown these results. This is a very substantial market niche because there are about 50 million standard PSA tests done every year and while not all of them receive a free PSA test, the cost of the latter is over $100 a piece.”

    About BioCurex, Inc.

    BioCurex, Inc. is a biotechnology company that is developing products based on patented and proprietary technology in the area of cancer diagnostics. The technology identifies a universal cancer marker known as RECAF.

    RECAF is a molecule that is present on cancer cells but not detected in significant levels on healthy cells or benign tumor cells. It is the receptor for alpha-fetoprotein and is classified as an oncofetal antigen due to its presence on both fetal and malignant tissues. This characteristic makes RECAF a more accurate indicator of cancer than most current tumor markers.

    BioCurex is commercializing its technology through licensing arrangements with companies that develop and market diagnostic tests for the large automated clinical laboratory setting, through development and marketing of non-automated clinical laboratory tests, through development of rapid, point-of-care test formats, and through marketing of its OncoPet RECAF test for cancer in companion animals.

    BioCurex has signed licensing agreements for its cancer detection blood tests with Abbott Laboratories (NYSE:ABT – News) and with Alere (NYSE:ALR – News), formerly Inverness Medical Innovations.

    Micro Cap Stock Industrial Nanotech, Inc. (INTK) Reports Energy Saving Project with Textile Manufacturer Arik Bey Tekstil

    Posted on September 12, 2011 by

    Industrial Nanotech, Inc. (INTK.PK)NAPLES, Fla.–Industrial Nanotech, Inc. (Pink Sheets:INTK.pk – News), an emerging global leader in nanoscience energy saving solutions, announced today that their Turkish distributor, Kolorgen Ltd, has completed installation of the Company’s patented Nansulate® thermal insulation coatings at the Beysehir, Konya, Turkey location of Arik Bey Tekstil Enerji ve Sinai Yatirimlar A.S. Nansulate® High Heat thermal insulation and corrosion prevention coating was used for insulation of dyeing machines and associated steam pipes to reduce energy consumption, lower surface temperature, and reduce carbon emissions. Once the initial project is complete, the project will continue at each of their two factories, the other is located in Istanbul, Turkey. Photos of the project are available at www.nansulate.com/arikbey.htm.

    “We are now at a stage that we are getting recognition from many other industries,” stated Vedat Bilgin, President, Kolorgen Ltd. “Over and over again, both in Turkey and other countries, we have proven to several industries that Nansulate® surpasses all other forms of insulation in terms of energy saving capability, durability and long service life in harsh environments. We now have a few ongoing projects with some leading textile companies in Turkey and abroad, as well as companies in other industries."

    Francesca Crolley V.P. Business Development, Industrial Nanotech, Inc., explains, “We have a very successful track record in the textile manufacturing industry for providing energy savings through insulation of equipment such as dyeing machines, steam pipes, boilers, and heat exchangers. We’ve worked with numerous textile companies, such a Coats plc who expects to reduce their steam consumption by 10 percent and their global carbon footprint by 2%, Henateks Textile, who documented an average 20% reduction in liquid natural gas with a 7 month payback, and numerous others, to reduce their energy savings significantly through use of Nansulate® advanced insulation technology. Our textile and other manufacturing clients have been very pleased with the multiple benefits the coatings offer, which are energy cost savings, reduction of carbon emissions, and improved worker safety by reducing surface temperature and heat expelled into the environment.”

    Arik Bey Tekstil Enerji ve Sinai Yatirimlar is owned by Akkanat Holding, a diversified group of companies, active in textiles, power generation and tourism. Arik Bey is a contract supplier for adidas, and both locations are listed on their July 2011 List of Authorized Suppliers – London 2012 Olympic and Paralympic Games.

    About Nansulate®

    Nansulate® is the Company’s patented product line of award winning, specialty coatings containing a nanotechnology based material and which provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. Nansulate® products are made in the USA. Additional information about the Company and its products can be found at their websites, (www.industrial-nanotech.com) and (www.nansulate.com). Blog: www.nansulate.com/nanoblog, Twitter:www.twitter.com/NanoPioneer, Facebook: www.facebook.com/Nansulate.

    About Industrial Nanotech Inc.

    Industrial Nanotech Inc. is a global nanoscience solutions and research leader and member of the U.S. Greenbuilding Council and an official ALLY organization with the U.S. Dept. of Energy "Save Energy Now"program. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.

    OTC Small Cap Penny Stock Marketing Worldwide Corp (MWWC.PK) Automotive Starts Its Production For GM’s Chevrolet Sonic

    Posted on by

    HOWELL, Mich., Sept. 12, 2011 — MWW Automotive Group (OTCQB: MWWC), a global design, engineering, and manufacturing firm serving some of the world’s leading automotive and industrial manufacturers, announced today that it is beginning production for the painting and fulfillment of interior parts for the new 2012 “Chevrolet Sonic,” which will be available for purchase in the fall of 2011.

    The MWW interior component package produced for the Chevrolet Sonic includes Door Trim, Window Console Covers, Trim Bars and Door Pulls, all finished and delivered from MWW’s Colortek Class-A painting facility inBaroda, Michigan.

    The Chevrolet Sonic has been in the planning stages at GM for many years, has received rave reviews and its pending launch represents a milestone for GM; the introduction of the only sub compact vehicle being built on U.S. soil. The Sonic will compete directly with the Ford Fiesta, Honda Fit and Toyota Yaris among others. Chevrolet is hinting that pricing will be competitive in the segment. The Sonic marks the return of the American small car, and not just in name. As part of GM’s restructuring, the Sonic will be assembled in Lake Orion, Michigan. For more information on the Sonic, please visit www.Chevrolet.com/Sonic .

    Chuck Pinkerton, CEO of MWW Automotive stated: “We are very excited to be involved in the launch of this ground breaking new GM model. The Chevrolet Sonic is one of several new MWW automotive projects that will commence production at the end of September 2011 and beginning of October and will run over the next three years. Expectations for the Sonic, the first US produced sub compact, are high and we are looking forward to significant and long lasting production runs. Producing the Sonic for GM and Chevrolet is another milestone on our path to further establish ourselves as one of the premier manufacturers for specialized painting and logistics projects and reflects our commitment to deliver only the highest quality product to our clients. Moving forward, we will continue to inform the public about our new projects, especially about our new industrial projects to come.”

    About MWW Automotive Group (MWW)

    MWW is headquartered in Howell, Michigan, with a “Class A” painting/assembly/logistics facility in Baroda, Michigan for the production of OE quality automotive and industrial products. The MWW Automotive Group (OTCQB: MWWC) delivers its in-house designed accessory products and Class A painting, assembly and logistics services directly to major global automobile manufacturers’ Vehicle Processing Centers (VPC) and/or assembly lines in the United States, Canada and Europe. MWW’s industrial products are delivered directly to the manufacturers for installation in their facilities. Noted for its adherence to the highest quality requirements and its advanced logistics capabilities, MWW products and services consistently meet and exceed customers’ expectations and requirements. MWW provides substantial added value to the sale of vehicles and industrial products for leading international automobile and industrial manufacturers such as Toyota, BMW, Hyundai, Kia Motors, GM, Ford, Deere and Whirlpool.  For more information please visit www.mwwautomotive.com or e-mailinvestorrelations@mwwautomotive.com.

    Penny Stock MEDISWIPE INC (MWIP.OB) Advances 116% on Exceeding $8,000,000 in Monthly Processing Volume

    Posted on September 13, 2011 by

    MEDISWIPE INC (MWIP.OB)LOS ANGELES, Sept. 13, 2011 — MediSwipe Inc. (http://www.MediSwipe.com) (OTCBB:MWIP.OB -News), a merchant payment solutions and financial products company for the medical health care industry and its wholly owned subsidiary 800 Commerce Inc. (www.800Commerce.com) a leading enabler and turnkey ecommerce solution provider including mobile payment solutions, today announced new merchant services agreements for September exceeding eight million ($8,000,000) dollars in monthly gross processing volume. The new merchant processing agreements include wellness centers, e-commerce and high risk merchant accounts. Under the newly signed agreements, MediSwipe and 800 Commerce will provide merchant services, gift/ loyalty cards and personal digitized healthcare records to the new merchant network. The Company will also update shareholders on the exact filing date of the 800 Commerce Spin-off and dividend share within the next few days.

    "We are extremely pleased with the performance of our agent network and organic growth as to new merchant accounts as a direct result of expanding our markets to all high risk markets beyond the medicinal sector. Revenues as a result of these new accounts each month will mark a progressive upward trend, where previously we have been unable to show meaningful revenues due to prior banking and agent agreements with most revenues taken after distribution to several entities, as well as being limited to the medicinal marijuana sector alone. Typically, profit margins now flowing to the Company will be anywhere from 1%-3% monthly on gross processing volume. We will continue to service and be a leading provider of financial services to the medicinal sector, while at the same time create increased shareholder value through our high risk banking relationships to all businesses that seek our services," stated B. Michael Friedman, CEO of MediSwipe Inc.

    About MediSwipe Inc.

    MediSwipe Inc. (www.MediSwipe.com) offers a full spectrum of secure and reliable transaction processing and security solutions for the medical and healthcare industries, using traditional, Internet Point-of-Sale (POS), e-commerce and mobile (wireless) payment solutions. The Company now also offers digitized personal health records in conjunction with Industry Alliance Partners. MediSwipe offers reliable merchant payment solutions and closed loop pre-paid stored value and loyalty cards as a unique cash alternative to these regulated and e-commerce businesses specializing within the healthcare sector.

     

    FORWARD-LOOKING DISCLAIMER

    This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.

    OTC Penny Stock Company Fox Petroleum, Inc. (FXPT.PK) Declares Terms of Oil and Gas Acquisitions

    Posted on by

    Fox Petroleum, Inc. (FXPT.PK)NEW YORK, NY–(09/13/11)- Fox Petroleum Inc. (Pinksheets: FXPT.PK – News) announced today that it is acquiring Renfro Energy LLC and Cameron Parish Pipelines LLC for three-hundred thousand dollars ($300,000) in cash.

    Renfro Energy LLC is a Dallas, Texas based limited liability company formed in March 2002 as an asset holding company to house existing oil and gas assets located in Texas, Oklahoma and for acquisitions identified in Louisiana. Since 1995, Renfro Energy LLC and its predecessor company have bought and sold over $6 million of oil and gas properties through approximately fifteen acquisitions. The assets are located in the heart of the Johnson Bayou, Louisiana on the northern flank of the Cameron Meadows Salt Dome.

    In 2003, Renfro Energy LLC obtained a new lease on the property and began operations. Estimated recoverable oil reserves from the current zones are 40,000 barrels with an additional 100,000 barrels of oil reserves from a behind pipe zone in one of the existing wells.

    "Currently there are four wells on the property, two oil wells, one salt-water disposal and one shut in well with future utility," said James Renfro, President of Fox Petroleum Inc. "We fully expect that the two oil wells within thirty days expect to be producing between fifteen to twenty barrels a day or close to six hundred barrels per month," he added.

    Mr. William Lieberman, CEO of Fox Petroleum, said, "We look very forward to these acquisitions that no doubt will add significantly to the bottom line of Fox Petroleum in due course. We feel that we are paying a very decent price for long term assets that have great value. We are very confident in working with Mr. Renfro in all capacities, and feel that all shareholders will benefit in the long term. This is strictly a cash deal to start, Fox Petroleum is giving up no equity at this time."

    Fox Petroleum expects to complete the transaction of both Renfro Energy LLC and Cameron Parish Pipelines LLC by October 31, 2011 upon completion of PCAOB audits.

    About Fox Petroleum, Inc. (FXPT.PK)

    Fox Petroleum Inc., a development stage company, engages in the identification, exploration, acquisition, and development of prospective oil and gas properties. It holds oil and gas interests in a United Kingdom onshore license; and joint venture interests in Texas. The company was formerly known as Nova Resources Inc. and changed its name to Fox Petroleum Inc. in February 2007 to reflect the new direction of its business of oil and gas exploration and development activities. Fox Petroleum Inc. was founded in 2004 and is based in New York, New York.

    MWIP, CSCE, FXPT, GDGI, GRPR Are the Crazy Penny Stocks Midday Movers

    Posted on by

    MEDISWIPE INC (MWIP.OB) Leads Opening Bell Report

    September 13, 2011 West Palm Beach, Fla –Undiscovered Equities.com  a top rated newsletter analyzes the most active & explosive OTC, OTCBB, NASDAQ,  NYSE Micro Cap Penny Stocks such as MWIP with huge volume and positive change at the open bell.

    The most active bullish small cap penny stocks at the open of trading includes: MWIP, CSCE, FXPT, GDGI, GRPR.

     

    LOS ANGELES, Sept. 13, 2011  MediSwipe Inc. (http://www.MediSwipe.com) (OTCBB:MWIP.OB -News), a merchant payment solutions and financial products company for the medical health care industry and its wholly owned subsidiary 800 Commerce Inc. (www.800Commerce.com) a leading enabler and turnkey ecommerce solution provider including mobile payment solutions, today announced new merchant services agreements for September exceeding eight million ($8,000,000) dollars in monthly gross processing volume. The new merchant processing agreements include wellness centers, e-commerce and high risk merchant accounts. Under the newly signed agreements, MediSwipe and 800 Commerce will provide merchant services, gift/ loyalty cards and personal digitized healthcare records to the new merchant network. The Company will also update shareholders on the exact filing date of the 800 Commerce Spin-off and dividend share within the next few days.

     

     

    About Undiscovered Equities.com Undiscovered Equities.com is looking for hot penny stock picks exposed and on the move showing unusual movement like MWIP hich could be a popular top performing hot OTC small cap penny stock.

    1158737_the_backgrounderUndiscovered Equities.com knows traders and investors are looking for exciting OTC volume movers such as MWIP to put on there speculative penny stock pick watch list for review. The Undiscovered Equities.com penny stock finder trading system locates the best small cap, micro cap penny stocks like MWIP that have unusual movements with news, popular penny stocks with big gains, and strong stock trends.

    Undiscovered Equities.com looks for exciting, explosive penny stocks like MWIP with the right mixture of powerful volume and low market capitalization to give day-traders & investors an opportunity to build a penny stock watch list consisting of the most notable penny stocks with high volume and positive change that can become explosive mega volume penny picks at any given time. Disclaimer Undiscovered Equities.com has not been compensated for any profiles featured in this report.

    Undiscovered Equities.com does not own shares in any of the above profiles. The assembled information distributed by Undiscovered Equities.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Undiscovered Equities.com does expect that investors will buy and sell securities based on information assembled and presented herein.

    Undiscovered Equities.com will not be responsible in any way for or accept any liability for any losses arising from an investor’s reliance on or use of information obtained from our website or emails. Always do your own due diligence, and consult your financial advisor.

    Cancer Test Maker RADIENT PHARM CP (RXPC.PK) Files International Patents in Australia and New Zealand

    Posted on September 14, 2011 by

    RADIENT PHARM CP (RXPC.PK)TUSTIN, CA–09/14/11- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC.PK -News) (Pinksheets: RXPC.PK – News), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced it has filed for patent protection for its proprietary Onko-Sure® cancer test in Australia and New Zealand.

    "Building an intellectual property position in foreign markets protects and supports sales of our proprietary Onko-Sure® cancer test globally. Both Australia and New Zealand have highly developed healthcare markets where we believe Onko-Sure® can add value as a minimally invasive, relatively low cost cancer diagnostic," stated Radient Chairman and CEO Douglas MacLellan.

    The Onko-Sure® test kit is a 96-well ELISA test kit sold to clinical reference labs. Labs run individual tests prescribed by doctors. Blood samples can be run, in duplicate, for 40 people, on each test kit. Onko-Sure® is a non-invasive cancer blood test that has been shown, in a large body of published clinical research, to be effective in the detection of 19 different cancers.

    For additional information on Radient Pharmaceuticals Corporation and its products visit: www.radient-pharma.com or e-mail info@radient-pharma.com. For Investor Relations contact Dilek Mir at: ir@radient-pharma.com or 714-881-0244.

    The following table is intended to provide the latest information on Radient’s business metrics:

     
    ---------------------------------------------------
    RPC's Business Metrics
    ---------------------------------------------------
    Cash on hand: $580,000*
    *Approximate amount as of September 12, 2011
    ---------------------------------------------------
    Shares Outstanding:  435 million*
    *Approximate number as of September 12, 2011.
     750 million shares authorized.
    ---------------------------------------------------
    Outstanding Warrants & Options:  111 million*
    *Approximate number as of September 12, 2011
    ---------------------------------------------------

    About Radient Pharmaceuticals:

    Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is dedicated to saving lives and money for patients and global healthcare systems through the deployment of its FDA-cleared In Vitro Diagnostic Onko-Sure® cancer test kit for colorectal cancer treatment and recurrence monitoring. The Company’s focus is on the discovery, development and commercialization of unique high-value diagnostic tests that will help physicians answer important clinical questions related to early disease state detection, treatment strategy, and the monitoring of disease progression or recurrence. To learn more about our company, products, and potentially life-saving cancer test, visit www.radient-pharma.com.

    Forward-Looking Statements:

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company’s operations, markets, services, products, and prices. With respect to Radient Pharmaceuticals Corporation, except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

    « Older Entries